FDA Draft Guidance On Decentralized Clinical Trials

Draft Guidance provides recommendations such as design considerations, conduct of remote clinical trial activities, use of digital health technologies to remotely acquire data, roles of the sponsor and investigators, informed consent and institutional review board oversight

Related Keywords

Robertm Califf , , Drug Administration , Draft Guidance , Decentralized Clinical Trials , Decentralized Clinical , Digital Health Technologies , Remote Data Acquisition , Clinical Investigations , Legal , Business , Government , Fda , Food And Drug Administration , Fact , 020 Guidance , Telehealth , Digital Health , Trial Procedures , Clinical Trial , Participant , Laboratories , Nvestigator Oversight , Da Public Comments ,